Rett Syndrome Clinical Trial
Official title:
The Diagnostic Experience of Male Rett Syndrome
| NCT number | NCT06346106 |
| Other study ID # | 23-0075 |
| Secondary ID | |
| Status | Recruiting |
| Phase | |
| First received | |
| Last updated | |
| Start date | May 24, 2023 |
| Est. completion date | April 30, 2024 |
The Diagnostic Experience of Male Rett Syndrome collects information on the lived experiences of parents or caregivers to boys with Rett Syndrome. Key information examined includes the process of getting a male Rett syndrome diagnosis, your son's systems of care, and your priorities for his health needs. Enrolled participants will complete an online survey with questions about having a son with Rett Syndrome. The Diagnostic Experience of Male Rett Syndrome study is available to parents or caregivers to boys (alive or passed) with Rett Syndrome. Compensation is not provided.
| Status | Recruiting |
| Enrollment | 80 |
| Est. completion date | April 30, 2024 |
| Est. primary completion date | April 30, 2024 |
| Accepts healthy volunteers | |
| Gender | Male |
| Age group | 0 Years to 100 Years |
| Eligibility | Inclusion Criteria: - English-speaking parents (over the age of 18) of male children (all ages, alive or deceased) with confirmed genetic diagnosis of male RTT Exclusion Criteria: - parents of male MECP2 duplication syndrome |
| Country | Name | City | State |
|---|---|---|---|
| United States | University of Colorado Anschutz Medical Campus | Aurora | Colorado |
| Lead Sponsor | Collaborator |
|---|---|
| Children's Hospital Colorado | International Rett Syndrome Foundation, Rocky Mountain Rett Association, University of Alabama at Birmingham, University of Colorado, Denver, University of Pennsylvania, Vanderbilt University School of Medicine |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Diagnostic experiences | Qualitative interview | retrospective from birth | |
| Primary | Attainment of developmental milestones and any regressions | Remote survey of developmental milestones, reported in months | retrospective from birth | |
| Primary | QI-disability | "QI-Disability" is a published remote survey of symptom ratings that are combined into an aggregate score of quality of life | retrospective over prior month | |
| Primary | Parent priorities for care and counseling | Remote survey the asks parents to prioritize with a rating scale their priorities for patient care | retrospective from birth | |
| Primary | Parenting experience | Remote survey the asks parents to rate with a rating scale their parenting experience | retrospective from birth | |
| Primary | Information regarding child's death, if applicable | Questionnaire that asks parents about the details of their child's death, if applicable | retrospective from birth | |
| Secondary | Family demographics | Questionnaire | retrospective, over last 12 months | |
| Secondary | Systems of supports | Questionnaire | retrospective, over last 12 months | |
| Secondary | Healthcare preferences | Questionnaire | retrospective, over last 12 months |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04988867 -
An Open-Label Study of Trofinetide for the Treatment of Girls Two to Five Years of Age Who Have Rett Syndrome
|
Phase 2/Phase 3 | |
| Recruiting |
NCT00069550 -
Independent Studies of Dextromethorphan and of Donepezil Hydrochloride for Rett Syndrome
|
Phase 3 | |
| Enrolling by invitation |
NCT06139172 -
Promoting Prosocial Behavior in Syndromic Intellectual and Developmental Disabilities
|
N/A | |
| Not yet recruiting |
NCT04014985 -
Patients With RETT Syndrome
|
N/A | |
| Not yet recruiting |
NCT04041713 -
A Pilot Study of an Antioxidant Cocktail vs. Placebo in the Treatment of Children and Adolescents With Rett Syndrome
|
Phase 2 | |
| Completed |
NCT02705677 -
Biobanking of Rett Syndrome and Related Disorders
|
||
| Terminated |
NCT02790034 -
Evaluation of the Efficacy, Safety, and Tolerability of Sarizotan in Rett Syndrome With Respiratory Symptoms
|
Phase 2/Phase 3 | |
| Enrolling by invitation |
NCT03655223 -
Early Check: Expanded Screening in Newborns
|
||
| Recruiting |
NCT05932589 -
Neurophysiologic Biomarkers in Rett Syndrome
|
||
| Recruiting |
NCT04463316 -
GROWing Up With Rare GENEtic Syndromes
|
||
| Completed |
NCT04776746 -
Open-Label Extension Study of Trofinetide for Rett Syndrome
|
Phase 3 | |
| Completed |
NCT04181723 -
Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome (LAVENDERâ„¢)
|
Phase 3 | |
| Enrolling by invitation |
NCT03836300 -
Parent and Infant Inter(X)Action Intervention (PIXI)
|
N/A | |
| Completed |
NCT04514549 -
ASSESSING EMERALD AND MC10 BIOSTAMP nPOINT BIOSENSORS FOR RETT SYNDROME
|
||
| Completed |
NCT02738281 -
Natural History of Rett Syndrome & Related Disorders
|
||
| Terminated |
NCT02562820 -
An Exploratory Trial of Ketamine for the Treatment of Rett Syndrome
|
Phase 1 | |
| Completed |
NCT05687214 -
Osteopathic Manipulative Treatment for Constipation in People With Rett Syndrome
|
N/A | |
| Recruiting |
NCT06199700 -
Esketamine for the Treatment of Rett Syndrome
|
Early Phase 1 | |
| Completed |
NCT03941444 -
ANAVEX2-73 Study in Patients With Rett Syndrome
|
Phase 3 | |
| Not yet recruiting |
NCT06338267 -
Validation of Innovative Biosensors for Rett Autonomic Symptom Tracking
|